changes.mady.by.user April Seaward
Saved on Apr 06, 2022
Saved on May 24, 2022
Bourgault, Z., Matheson, J., Mann, R.E., Brands, B., Wickens, C.M., Tiwari, A.K., Zai, C.C., Kennedy, J. & Le Foll, B. 2022. Mu opioid receptor gene variant modulates subjective response to smoked cannabis. Am J Transl Res, 14(1):623-632.
Brubacher, J.R., Chan, H., Erdelyi, S., Staples, J.A., Asbridge, M. & Mann, R.E. 2022. Cannabis Legalization and Detection of Tetrahydrocannabinol in Injured Drivers. N Engl J Med, 386(2):148-156.
Zandi, A.S., Comeau, F., Mann, R.E., Di Ciano, P., Arslan, E.P., Murphy, T., Le Foll, B. & Wickens, C.M. 2021. Preliminary Eye-Tracking Data as a Nonintrusive Marker for Blood Δ-9-Tetrahydrocannabinol Concentration and Drugged Driving. Cannabis and Cannabinoid Research, 6(6):537-547.
Nigatu, Y.T., Elton-Marshall, T., Mann, R.E. & Hamilton, H.A. 2022. Associations of cannabis use, opioid use, and their combination with serious psychological distress among Ontario adults. Stress Health, 38(1):38-46.
Wickens, C.M., Wright, M., Mann, R.E., Brands, B., Di Ciano, P., Stoduto, G., Fares, A., Matheson, J., George, T.P., Rehm, J., Shuper, P.A., Sproule, B., Samohkvalov, A., Huestis, M.A. & Le Foll, B. 2022. Separate and combined effects of alcohol and cannabis on mood, subjective experience, cognition and psychomotor performance: A randomized trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 118:110570.